Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > Journal Article	Display all items Journal Articles Discussion Articles Comments Discussions Conferences/Workshops Availabilities Grants/Funds Information/News

(Journal Article): Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.
 
Meier JJ, Gallwitz B, Nauck MA
 
IN: BioDrugs 2003; 17(2):93-102
Impact Factor(s) of BioDrugs: 1.905 (2004), 2.277 (2003), 0.503 (2001)

ABSTRACT: Although the insulinotropic actions of gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) have been known for almost 2 decades, the incretin hormones have not... Click HERE for details